AJR Am J Roentgenol

1. FERRAIOLI G
   Editorial Comment: A Step Toward the Clinical Application of Quantitative Ultrasound in the Diagnosis of Steatotic Liver Disease.
   AJR Am J Roentgenol. 2024 Apr 3. doi: 10.2214/AJR.24.31215.
   

   >> Share

   
   
2. KIERANS AS, Borhani AA
   Beyond the AJR: The Need for Studies Evaluating the Added Value of Abbreviated MRI for Hepatocellular Carcinoma Surveillance in Geographically Diverse Prospective Cohorts.
   AJR Am J Roentgenol. 2024 Jul 3. doi: 10.2214/AJR.24.31662.
   

   >> Share

   
   

   
   Am J Gastroenterol

3. FRENETTE C, Mendiratta-Lala M, Salgia R, Wong RJ, et al
   ACG Clinical Guideline: Focal Liver Lesions.
   Am J Gastroenterol. 2024;119:1235-1271.
   

   >> Share

   
   

   
   Dig Dis Sci

4. GUAN Y, Gan Y, An J
   Clinical Characteristics and Prognosis of Early-Onset Hepatocellular Carcinoma: A Retrospective Cohort Study Based on Population Data.
   Dig Dis Sci. 2024 Jul 4. doi: 10.1007/s10620-024-08549.
   

   >> Share

   
   

   
   Eur Radiol

5. CAO J, Shon A, Yoon L, Kamaya A, et al
   Diagnostic performance of CT/MRI LI-RADS v2018 in non-cirrhotic steatotic liver disease.
   Eur Radiol. 2024 Jul 1. doi: 10.1007/s00330-024-10846.
   

   >> Share

   
   

   
   Gastroenterology

6. ZENG T, Xiong J, Li X
   A rare cause of hepatic mass with high metabolic activity and jaundice.
   Gastroenterology. 2024 Jun 29:S0016-5085(24)05173.
   

   >> Share

   
   
7. SUTTON H, Bhat M
   Novel migratory hepatocyte population contributes to liver regeneration in acute liver injury.
   Gastroenterology. 2024 Jun 27:S0016-5085(24)05176.
   

   >> Share

   
   

   
   Gut

8. HA S, Wong VW, Zhang X, Yu J, et al
   Interplay between gut microbiome, host genetic and epigenetic modifications in MASLD and MASLD-related hepatocellular carcinoma.
   Gut. 2024 Jun 29:gutjnl-2024-332398. doi: 10.1136/gutjnl-2024-332398.
   

   >> Share

   
   

   
   Hepatology

9. PREMKUMAR M, Karvellas CJ, Kulkarni AV, Bhujade H, et al
   Role of Point-of-Care ultrasound (POCUS) in clinical hepatology.
   Hepatology. 2024 Jul 1. doi: 10.1097/HEP.0000000000000990.
   

   >> Share

   
   
10. KENT D, Ng SS, Syanda AM, Khoshkenar P, et al
    Reduction of Z alpha-1 antitrypsin polymers in human iPSC-hepatocytes and mice by LRRK2 inhibitors.
    Hepatology. 2024 Jul 2. doi: 10.1097/HEP.0000000000000969.
    

    >> Share

    
    

    
    Int J Cancer

11. HO NT, Abe SK, Rahman MS, Islam R, et al
    Diabetes is associated with increased liver cancer incidence and mortality in adults: A report from Asia Cohort Consortium.
    Int J Cancer. 2024;155:854-870.
    

    >> Share

    
    

    
    J Comput Assist Tomogr

12. COX V, Javle M, Sun J, Kang H, et al
    Radiogenomics of Intrahepatic Cholangiocarcinoma: Correlation of Imaging Features With BAP1 and FGFR Molecular Subtypes.
    J Comput Assist Tomogr. 2024 Jul 5. doi: 10.1097/RCT.0000000000001638.
    

    >> Share

    
    

    
    J Gastroenterol

13. AMPUERO J, Aller R, Gallego-Duran R, Crespo J, et al
    The biochemical pattern defines MASLD phenotypes linked to distinct histology and prognosis.
    J Gastroenterol. 2024;59:586-597.
    

    >> Share

    
    

    
    J Gastroenterol Hepatol

14. NAKASHIMA R, Kitano Y, Okabe H, Tanizaki T, et al
    Rising pseudocysts in the hepatoduodenal ligament caused by a ruptured intraductal papillary mucinous neoplasm with surgical treatment.
    J Gastroenterol Hepatol. 2024 Jul 1. doi: 10.1111/jgh.16669.
    

    >> Share

    
    
15. SUZUKI T, Matsuura K, Suzuki Y, Okumura F, et al
    Serum interleukin-6 levels at the start of the second course of atezolizumab plus bevacizumab therapy predict therapeutic efficacy in patients with advanced hepatocellular carcinoma: a multicenter analysis.
    J Gastroenterol Hepatol. 2024 Jun 28. doi: 10.1111/jgh.16672.
    

    >> Share

    
    

    
    J Hepatol

16. MENDOZA YP, Tsouka S, Semmler G, Seubnooch P, et al
    Metabolic phenotyping of patients with Advanced Chronic Liver Disease for better characterization of Cirrhosis Regression.
    J Hepatol. 2024 Jun 27:S0168-8278(24)02334-1. doi: 10.1016/j.jhep.2024.
    

    >> Share

    
    

    
    J Pediatr Surg

17. ZIOGAS IA, Kakos CD, Kokkinakis S, Hills-Dunlap JL, et al
    Management and Outcomes of Hepatoblastoma in Patients With Trisomy 18: A Systematic Review and Pooled Analysis of 70 Patients.
    J Pediatr Surg. 2024 Jun 11:S0022-3468(24)00363.
    

    >> Share

    
    

    
    Oncogene

18. LI X, He W, Chen X, Zhang Y, et al
    TRIM45 facilitates NASH-progressed HCC by promoting fatty acid synthesis via catalyzing FABP5 ubiquitylation.
    Oncogene. 2024;43:2063-2077.
    

    >> Share

    
    

    
    PLoS One

19. PAUKNER M, Ladner DP, Zhao L
    Dynamic risk prediction of survival in liver cirrhosis: A comparison of landmarking approaches.
    PLoS One. 2024;19:e0306328.
    

    >> Share

    
    
20. YANG X, Liao Y, Fan L, Lin B, et al
    High-intensity focused ultrasound ablation combined with immunotherapy for treating liver metastases: A prospective non-randomized trial.
    PLoS One. 2024;19:e0306595.
    

    >> Share

    
    
21. 
    Expression of Concern: The Antimetastatic Effects of Resveratrol on Hepatocellular Carcinoma through the Downregulation of a Metastasis-Associated Protease by SP-1 Modulation.
    PLoS One. 2024;19:e0306742.
    

    >> Share

    
    
22. MATSUBARA K, Kuroda S, Kobayashi T, Ide K, et al
    Feasibility, safety, and efficacy of intraoperative magnetic resonance imaging-guided hepatectomy for small hepatocellular carcinoma: A retrospective study.
    PLoS One. 2024;19:e0306307.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share